T-Dxd
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
T-Dxd
Apr 29, 2024, 15:54 |
Insight
Toni Choueiri: Big news to start the day: DESTINY-Breast06 Phase III trial
Toni Choueiri shared on X: "Big news to start the day: DESTINY-Breast06 Phase III trial…
Apr 27, 2024, 15:34 |
Insight
Erika Hamilton: Happy to share our publication re: T-DXd vs. T-DM1 among patients with brain metastasis in DB-03
Erika Hamilton shared on LinkedIn: "Happy to share our publication re: T-DXd vs. T-DM1 among…
Apr 26, 2024, 11:05 |
Blog
Paolo Tarantino: Wonderful experience to brainstorm about the agnostic potential of ADCs with Roberto Carmagnani Pestana
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared a post by Roberto Carmagnani Pestana,…
Apr 16, 2024, 01:57 |
Insight
Cancer Network's top 5 articles of the week
Quoting Cancer Network on X/Twitter: "View our top 5 articles of the week: FDA Grants…
Apr 16, 2024, 00:17 |
Blog
Paolo Tarantino: We review best practices and future perspectives for the identification of patients with HER2-low Breast Cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn: "In our latest…
Jan 29, 2024, 13:37 |
Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
Dec 30, 2023, 17:51 |
Opinion
Paolo Tarantino: Happy to have worked with Sarah Sammons and Nancy Lin at the ph2 DATO-Base trial
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared a post…
Jul 27, 2023, 07:14 |
Blog
DAISY Such a key publication in our growing understanding of T-DXd - Stephanie Graff
DAISY Such a key publication in our growing understanding of T-DXd, particularly across the spectrum…
All:
8
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube